<p>最近几周，全球市场显示出乐观迹象，因为美国和中国之间的贸易紧张局势似乎正在缓解，这推动了美国股市的上涨，并导致纳斯达克综合指数等主要指数的增长。在这种谨慎经济复苏的背景下，投资者通常会寻找内部持股比例较高的成长型公司，因为这些股票可以提供管理层对其业务发展轨迹的信心以及在市场不确定性下的潜在韧性。</p>
<h3>全球内部持股比例高的十大成长型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>AcrelLtd (SZSE:300286)</td>
<td>34.2%</td>
<td>34.9%</td>
</tr>
<tr>
<td>Seojin SystemLtd (KOSDAQ:A178320)</td>
<td>32.1%</td>
<td>39.3%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.8%</td>
<td>43.1%</td>
</tr>
<tr>
<td>Vow (OB:VOW)</td>
<td>13.1%</td>
<td>111.2%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>36.4%</td>
<td>40.2%</td>
</tr>
<tr>
<td>Global Tax Free (KOSDAQ:A204620)</td>
<td>20.8%</td>
<td>35.1%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>37.4%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>22.6%</td>
<td>88.2%</td>
</tr>
<tr>
<td>Nordic Halibut (OB:NOHAL)</td>
<td>29.7%</td>
<td>60.7%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>13.6%</td>
<td>74.7%</td>
</tr>
</tbody>
</table>
<p>点击此处查看我们快速增长的全球内部持股比例高的 856 只股票的完整列表。</p>
<p>让我们更仔细地看看我们从筛选公司中挑选的几只股票。</p>
<h2>润本股份 (SHSE:603193)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> 润本股份有限公司专注于蚊虫驱避产品、婴儿护理产品和精油产品的研究、生产和销售，市值为 143.5 亿人民币。</p>
<p><strong>运营：</strong> 公司的收入主要来自个人护理产品部门，产生了 13.9 亿人民币的收入。</p>
<p><strong>内部持股比例：</strong> 29.6%</p>
<p><strong>收入增长预测：</strong> 每年 23%。</p>
<p>润本股份的收入预计每年增长 23%，超过了更广泛的中国市场。尽管预期的 ROE 为 17.8% 低于基准，但其收益增长仍然显著，达到每年 23.5%，尽管略低于市场平均水平。最近的第一季度业绩显示出强劲表现，销售额从去年同期的 1.6668 亿人民币上升至 2.4003 亿人民币，净收入增加至 4420 万人民币，反映出强劲的运营势头，近期没有报告重大内部交易活动。</p>
<ul>
<li>解锁我们对润本股份股票分析的全面见解，详见本增长报告。</li>
<li>我们的润本股份估值报告中的分析暗示其股价相较于估计价值被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/41571584-04fe-437d-8261-8c6c369a4bae/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/41571584-04fe-437d-8261-8c6c369a4bae/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:603193 截至 2025 年 4 月的收益和收入增长</p>
<h2>武汉光电 (SZSE:002414)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 武汉光电有限公司专注于亚洲红外热成像技术的研究、开发、生产和销售，市值为 322.4 亿人民币。</p>
<p><strong>运营：</strong> 公司的收入主要来自其他电子设备制造，金额为 26.2 亿人民币，以及技术服务行业，贡献了 4278 万人民币。</p>
<p><strong>内部持股比例：</strong> 27.1%</p>
<p><strong>收入增长预测：</strong> 每年 27.6%。</p>
<p>武汉光电的收入预计每年增长 27.6%，超过更广泛的中国市场增长率。尽管预期的 ROE 为 9.5% 较低，但预计公司将在三年内实现盈利，表明其市场利润增长潜力高于平均水平。最近的第一季度业绩显示出显著改善，销售额从 4.6797 亿人民币增加至 6.8076 亿人民币，净收入大幅上升至 8355 万人民币，近期没有报告重大内部交易活动。</p>
<ul>
<li>在这里深入了解武汉光电的完整分析未来增长报告。</li>
<li>我们的估值报告显示武汉光电可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6a0b0920-be46-4387-a40e-f0d75583886e/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6a0b0920-be46-4387-a40e-f0d75583886e/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:002414 截至 2025 年 4 月的收益和收入增长</p>
<h2>博创科技 (SZSE:300548)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 博创科技有限公司从事光通信领域集成光电设备的研究、开发、生产和销售，市值为 106.5 亿人民币。</p>
<p><strong>运营：</strong> 公司的收入部分包括来自电信市场的 6.6968 亿人民币和来自数据通信、消费和工业互联的 10.7 亿人民币。</p>
<p><strong>内部持股比例：</strong> 11.5%</p>
<p><strong>收入增长预测：</strong> 每年 21.6%。</p>
<p>博创科技预计每年收入增长 21.6%，超过中国市场的 12.6% 增长率，预计收益将显著增长，每年达到 42.4%。尽管其股价相较于估计的公允价值有显著折扣，并经历了股价波动，博创在 2024 年报告的全年销售额为 17.5 亿人民币，较前一年的 16.8 亿人民币有所上升，尽管净收入略微下降至 7207 万人民币，低于 8147 万人民币。</p>
<ul>
<li>在这里深入了解博创科技的具体情况，查看我们的详细增长预测报告。</li>
<li>根据我们的估值报告，博创科技的股价可能偏高。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300548 截至 2025 年 4 月的收益和收入增长</p>
<h2>抓住机会</h2>
<ul>
<li>在这里探索我们快速增长的全球公司中高管持股比例高的 856 个名字。</li>
<li>想要探索一些替代方案吗？稀土金属是大多数高科技设备、军事和防御系统以及电动车的原材料。全球竞赛正在进行，以确保这些关键矿物的供应。抢先一步，发现这少数开采这一重要战略资源的 23 只最佳稀土金属股票。</li>
</ul>
<p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑由内部人士直接持有的股票，不包括通过其他工具如公司和/或信托实体间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
<p>如果您想交易润本股份，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
<p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
<p>享受无隐藏费用，无账户最低要求，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
<p>赞助内容</p>

润本股份

长芯博创

<p>三家全球增长公司拥有较高的内部持股比例，预计将实现显著的收入增长：润本股份（内部持股 29.6%，收入增长预测 23%）、武汉光电（内部持股 27.1%，收入增长预测 27.6%）和博创科技（内部持股 11.5%，收入增长预测 21.6%）。在经济条件改善的背景下，这些公司有望超越更广泛的市场，并因管理层对其业务发展轨迹的信心而吸引投资者的关注</p>

<p>In recent weeks, global markets have shown signs of optimism as trade tensions between the U.S. and China appear to be easing, boosting U.S. equities and leading to gains in major indices such as the Nasdaq Composite. Amid this backdrop of cautious economic recovery, investors often look for growth companies with strong insider ownership, as these stocks can offer insights into management's confidence in their business trajectory and potential resilience against market uncertainties.</p>
<div class="lb-trans"><p>最近几周，全球市场显示出乐观迹象，因为美国和中国之间的贸易紧张局势似乎正在缓解，这推动了美国股市的上涨，并导致纳斯达克综合指数等主要指数的增长。在这种谨慎经济复苏的背景下，投资者通常会寻找内部持股比例较高的成长型公司，因为这些股票可以提供管理层对其业务发展轨迹的信心以及在市场不确定性下的潜在韧性。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership Globally</h3>
<div class="lb-trans"><h3>全球内部持股比例高的十大成长型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>AcrelLtd (SZSE:300286)</td>
<td>34.2%</td>
<td>34.9%</td>
</tr>
<tr>
<td>Seojin SystemLtd (KOSDAQ:A178320)</td>
<td>32.1%</td>
<td>39.3%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.8%</td>
<td>43.1%</td>
</tr>
<tr>
<td>Vow (OB:VOW)</td>
<td>13.1%</td>
<td>111.2%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>36.4%</td>
<td>40.2%</td>
</tr>
<tr>
<td>Global Tax Free (KOSDAQ:A204620)</td>
<td>20.8%</td>
<td>35.1%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>37.4%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>22.6%</td>
<td>88.2%</td>
</tr>
<tr>
<td>Nordic Halibut (OB:NOHAL)</td>
<td>29.7%</td>
<td>60.7%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>13.6%</td>
<td>74.7%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>AcrelLtd (SZSE:300286)</td>
<td>34.2%</td>
<td>34.9%</td>
</tr>
<tr>
<td>Seojin SystemLtd (KOSDAQ:A178320)</td>
<td>32.1%</td>
<td>39.3%</td>
</tr>
<tr>
<td>Pharma Mar (BME:PHM)</td>
<td>11.8%</td>
<td>43.1%</td>
</tr>
<tr>
<td>Vow (OB:VOW)</td>
<td>13.1%</td>
<td>111.2%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>36.4%</td>
<td>40.2%</td>
</tr>
<tr>
<td>Global Tax Free (KOSDAQ:A204620)</td>
<td>20.8%</td>
<td>35.1%</td>
</tr>
<tr>
<td>CD Projekt (WSE:CDR)</td>
<td>29.7%</td>
<td>37.4%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>22.6%</td>
<td>88.2%</td>
</tr>
<tr>
<td>Nordic Halibut (OB:NOHAL)</td>
<td>29.7%</td>
<td>60.7%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>13.6%</td>
<td>74.7%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 856 stocks from our Fast Growing Global Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击此处查看我们快速增长的全球内部持股比例高的 856 只股票的完整列表。</p>
</div><p>Let's take a closer look at a couple of our picks from the screened companies.</p>
<div class="lb-trans"><p>让我们更仔细地看看我们从筛选公司中挑选的几只股票。</p>
</div><h2>Runben Biotechnology (SHSE:603193)</h2>
<div class="lb-trans"><h2>润本股份 (SHSE:603193)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Runben Biotechnology Co., Ltd. focuses on the research, production, and sale of mosquito repellent products, baby care products, and essential oil products with a market cap of CN¥14.35 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 润本股份有限公司专注于蚊虫驱避产品、婴儿护理产品和精油产品的研究、生产和销售，市值为 143.5 亿人民币。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its personal products segment, which generated CN¥1.39 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自个人护理产品部门，产生了 13.9 亿人民币的收入。</p>
</div><p><strong>Insider Ownership:</strong> 29.6%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 29.6%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 23% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 每年 23%。</p>
</div><p>Runben Biotechnology's revenue is forecast to grow 23% annually, outpacing the broader CN market. Despite a lower-than-benchmark expected ROE of 17.8%, its earnings growth remains significant at 23.5% per year, although slightly below the market average. Recent Q1 results showed strong performance with sales rising to CNY 240.03 million from CNY 166.68 million year-over-year and net income increasing to CNY 44.2 million, reflecting robust operational momentum without substantial insider trading activity reported recently.</p>
<div class="lb-trans"><p>润本股份的收入预计每年增长 23%，超过了更广泛的中国市场。尽管预期的 ROE 为 17.8% 低于基准，但其收益增长仍然显著，达到每年 23.5%，尽管略低于市场平均水平。最近的第一季度业绩显示出强劲表现，销售额从去年同期的 1.6668 亿人民币上升至 2.4003 亿人民币，净收入增加至 4420 万人民币，反映出强劲的运营势头，近期没有报告重大内部交易活动。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Runben Biotechnology stock in this growth report.</li>
<li>The analysis detailed in our Runben Biotechnology valuation report hints at an inflated share price compared to its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁我们对润本股份股票分析的全面见解，详见本增长报告。</li>
<li>我们的润本股份估值报告中的分析暗示其股价相较于估计价值被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/41571584-04fe-437d-8261-8c6c369a4bae/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/41571584-04fe-437d-8261-8c6c369a4bae/chart/earnings-and-revenue-growth"/></p>
<p>SHSE:603193 Earnings and Revenue Growth as at Apr 2025</p>
<div class="lb-trans"><p>SHSE:603193 截至 2025 年 4 月的收益和收入增长</p>
</div><h2>Wuhan Guide Infrared (SZSE:002414)</h2>
<div class="lb-trans"><h2>武汉光电 (SZSE:002414)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Wuhan Guide Infrared Co., Ltd. focuses on the research, development, production, and sale of infrared thermal imaging technology in Asia with a market cap of CN¥32.24 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 武汉光电有限公司专注于亚洲红外热成像技术的研究、开发、生产和销售，市值为 322.4 亿人民币。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from Other Electronic Equipment Manufacturing, amounting to CN¥2.62 billion, and Technical Service Industry, contributing CN¥42.78 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其他电子设备制造，金额为 26.2 亿人民币，以及技术服务行业，贡献了 4278 万人民币。</p>
</div><p><strong>Insider Ownership:</strong> 27.1%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 27.1%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 27.6% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 每年 27.6%。</p>
</div><p>Wuhan Guide Infrared's revenue is projected to grow 27.6% annually, surpassing the broader CN market growth rate. Despite a low forecasted ROE of 9.5%, the company is expected to achieve profitability within three years, indicating above-average market profit growth potential. Recent Q1 results demonstrated significant improvement, with sales increasing to CNY 680.76 million from CNY 467.97 million and net income rising sharply to CNY 83.55 million, with no substantial insider trading activity reported recently.</p>
<div class="lb-trans"><p>武汉光电的收入预计每年增长 27.6%，超过更广泛的中国市场增长率。尽管预期的 ROE 为 9.5% 较低，但预计公司将在三年内实现盈利，表明其市场利润增长潜力高于平均水平。最近的第一季度业绩显示出显著改善，销售额从 4.6797 亿人民币增加至 6.8076 亿人民币，净收入大幅上升至 8355 万人民币，近期没有报告重大内部交易活动。</p>
</div><ul>
<li>Delve into the full analysis future growth report here for a deeper understanding of Wuhan Guide Infrared.</li>
<li>Our valuation report here indicates Wuhan Guide Infrared may be overvalued.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里深入了解武汉光电的完整分析未来增长报告。</li>
<li>我们的估值报告显示武汉光电可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6a0b0920-be46-4387-a40e-f0d75583886e/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/6a0b0920-be46-4387-a40e-f0d75583886e/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:002414 Earnings and Revenue Growth as at Apr 2025</p>
<div class="lb-trans"><p>SZSE:002414 截至 2025 年 4 月的收益和收入增长</p>
</div><h2>Broadex Technologies (SZSE:300548)</h2>
<div class="lb-trans"><h2>博创科技 (SZSE:300548)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Broadex Technologies Co., Ltd. engages in the research, development, production, and sale of integrated optoelectronic devices for optical communications both in China and internationally, with a market cap of CN¥10.65 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 博创科技有限公司从事光通信领域集成光电设备的研究、开发、生产和销售，市值为 106.5 亿人民币。</p>
</div><p><strong>Operations:</strong> The company's revenue segments include CN¥669.68 million from the Telecom Market and CN¥1.07 billion from Data communications, consumer and industrial interconnection.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入部分包括来自电信市场的 6.6968 亿人民币和来自数据通信、消费和工业互联的 10.7 亿人民币。</p>
</div><p><strong>Insider Ownership:</strong> 11.5%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 11.5%</p>
</div><p><strong>Revenue Growth Forecast:</strong> 21.6% p.a.</p>
<div class="lb-trans"><p><strong>收入增长预测：</strong> 每年 21.6%。</p>
</div><p>Broadex Technologies is forecasted to see revenue growth of 21.6% annually, outpacing the CN market's 12.6% growth rate, with earnings expected to grow significantly at 42.4% per year. Despite trading at a substantial discount to its estimated fair value and experiencing share price volatility, Broadex reported full-year sales of CNY 1.75 billion for 2024, up from CNY 1.68 billion in the previous year, though net income decreased slightly to CNY 72.07 million from CNY 81.47 million.</p>
<div class="lb-trans"><p>博创科技预计每年收入增长 21.6%，超过中国市场的 12.6% 增长率，预计收益将显著增长，每年达到 42.4%。尽管其股价相较于估计的公允价值有显著折扣，并经历了股价波动，博创在 2024 年报告的全年销售额为 17.5 亿人民币，较前一年的 16.8 亿人民币有所上升，尽管净收入略微下降至 7207 万人民币，低于 8147 万人民币。</p>
</div><ul>
<li>Dive into the specifics of Broadex Technologies here with our thorough growth forecast report.</li>
<li>According our valuation report, there's an indication that Broadex Technologies' share price might be on the expensive side.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里深入了解博创科技的具体情况，查看我们的详细增长预测报告。</li>
<li>根据我们的估值报告，博创科技的股价可能偏高。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/273e61dc-0e7f-4c24-8955-0d5ce0353744/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300548 Earnings and Revenue Growth as at Apr 2025</p>
<div class="lb-trans"><p>SZSE:300548 截至 2025 年 4 月的收益和收入增长</p>
</div><h2>Seize The Opportunity</h2>
<div class="lb-trans"><h2>抓住机会</h2>
</div><ul>
<li>Explore the 856 names from our Fast Growing Global Companies With High Insider Ownership screener here.</li>
<li>Want To Explore Some Alternatives? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 23 best rare earth metal stocks of the very few that mine this essential strategic resource.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里探索我们快速增长的全球公司中高管持股比例高的 856 个名字。</li>
<li>想要探索一些替代方案吗？稀土金属是大多数高科技设备、军事和防御系统以及电动车的原材料。全球竞赛正在进行，以确保这些关键矿物的供应。抢先一步，发现这少数开采这一重要战略资源的 23 只最佳稀土金属股票。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，采用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑由内部人士直接持有的股票，不包括通过其他工具如公司和/或信托实体间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
</div><p>If you're looking to trade Runben Biotechnology, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果您想交易润本股份，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受无隐藏费用，无账户最低要求，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>赞助内容</p>
</div>

三家全球增长型公司，内部持股比例高，预计收入增长可达 27%